2022
DOI: 10.1101/2022.07.18.500459
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

A unique H2B acetylation signature marks active enhancers and predicts their target genes

Abstract: Chromatin features are widely used for genome-scale mapping of enhancers. However, discriminating active enhancers from other cis-regulatory elements, predicting enhancer strength, and identifying their target genes remains challenging. Here we establish histone H2B N-terminus multisite lysine acetylation (H2BNTac) as a genuine signature of active enhancers. H2BNTac prominently marks candidate active enhancers and their target promoters and discriminates them from ubiquitously active promoters. Two mechanisms … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 77 publications
0
10
0
Order By: Relevance
“…Consistent with our data, recent work mutating H3 and/or H3.3 Lysine 27 sites to Arginine, which cannot be acetylated did not impact either naive gene expression or the activation of the formative program in differentiating ESCs [14,15]. However, these findings are interpreted as a lack of a requirement for H3K27ac rather than an inability to recruit enhancer CBP/P300 at large where we also expect a loss in other active enhancer histone acetylations deposited by CBP/P300 such as H2B acetylation [42]. Either way, it is unclear whether many of the sites dependent on MLL3/4 for active histone marks are dispensable for gene expression changes and or these sites are functional enhancers without an active histone signature.…”
Section: Discussionmentioning
confidence: 53%
“…Consistent with our data, recent work mutating H3 and/or H3.3 Lysine 27 sites to Arginine, which cannot be acetylated did not impact either naive gene expression or the activation of the formative program in differentiating ESCs [14,15]. However, these findings are interpreted as a lack of a requirement for H3K27ac rather than an inability to recruit enhancer CBP/P300 at large where we also expect a loss in other active enhancer histone acetylations deposited by CBP/P300 such as H2B acetylation [42]. Either way, it is unclear whether many of the sites dependent on MLL3/4 for active histone marks are dispensable for gene expression changes and or these sites are functional enhancers without an active histone signature.…”
Section: Discussionmentioning
confidence: 53%
“…Although H3K27ac, a residue acetylated by p300/CBP, has been used as a marker for active promoters and enhancers 17 , it is absent in many p300-enriched chromatin regions 18 and is dispensable for enhancer activity of gene transcription in mouse embryonic stem cells 19 . In contrast, possibly through transcription-coupled histone exchange, H2BNTac better correlates with enhancer activity than any other known chromatin marks, with RNA transcription found in 79% of all H2BNTac-positive regions 16 . Importantly, the acetyltransferase activity of p300 responsible for H2BNTac 15 is a key driver of rapid enhancer activation and is essential for promoting the recruitment of RNA polymerase II (RNAPII) at virtually all enhancers and enhancer-regulated genes 20 .…”
mentioning
confidence: 84%
“…Indeed, p300 acetylates NT of H2A.Z, an evolutionarily conserved variant of H2A, through the bromodomain-mediated H4NTac 'reader' activity 14 . Interestingly, H2BNT is acetylated only by p300/CBP 15 , which is considered a genuine signature of active enhancers and their target promoters 16 .…”
mentioning
confidence: 99%
“…Histone modification is widely used as a means to classify enhancers according to their activity: H3K4me1 and the binding of trithorax-related mixed lineage leukemia (MLL) complex define primed or active enhancers; H3K27me3 is a key marker of poised or inactive enhancers; histone H3 lysine 27 acetylation (H3K27ac) is a hallmark of transcriptionally active enhancers ( Figure 1 ) [ 11 , 12 , 13 , 14 ]. Recent trends highlight that rather than defining active enhancers with H3K27ac, different histone acetylation marks, such as simultaneous acetylation of histone H4 at both K5 and K8 (H4K5acK8ac) [ 15 ], Das et al, [submitted], histone H2B N-terminus multisite lysine (e.g., K5, K12, K16, and K20) acetylation (H2BNTac [ 16 ]), H3K122ac [ 17 ], and H4K16ac [ 18 ], to define active enhancers are emerging. A large number of histone modifications have been implicated in gene transcription, where H3K4me3 has been associated with gene promoter regions [ 19 ].…”
Section: Histone Modifications Involved In E–p Interactionsmentioning
confidence: 99%
“…Importantly, local chromatin features, including marks indicating active (H3K27ac; [ 98 ]) or repressed (HP1 and H3K27me3; [ 97 ] chromatin, the presence of linker histone H1 proteins, and the associated TFs [ 103 ] cooperate in forming or dissolving phase-separated condensates ( Figure 2 ). In addition, newly identified marks of active enhancers, such as histone H4 hyperacetylation (H4K5acK8ac; Das et al, submitted) and H2BNTac [ 16 ], may contribute to the formation of phase-separated condensates. As directed by local chromatin features (e.g., in SEs), such phase-separated condensates could mediate systematic loading of the transcriptional machinery to active gene promoters [ 102 ], thus facilitating the E–P interactions.…”
Section: E–p Interactions In Llpsmentioning
confidence: 99%